Bell Bank’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,727
Closed -$841K 187
2024
Q2
$841K Sell
1,727
-362
-17% -$182K 0.07% 101
2024
Q1
$1.13M Sell
2,089
-300
-13% -$164K 0.1% 90
2023
Q4
$1.33M Sell
2,389
-212
-8% -$99.5K 0.13% 81
2023
Q3
$1.14M Sell
2,601
-112
-4% -$55.9K 0.12% 88
2023
Q2
$1.36M Sell
2,713
-142
-5% -$68K 0.14% 82
2023
Q1
$1.43M Sell
2,855
-177
-6% -$84.7K 0.15% 83
2022
Q4
$1.24M Sell
3,032
-31
-1% -$12K 0.14% 85
2022
Q3
$998K Buy
3,063
+26
+0.9% +$9.55K 0.13% 93
2022
Q2
$1.06M Buy
3,037
+178
+6% +$72.6K 0.13% 97
2022
Q1
$1.56M Buy
2,859
+209
+8% +$110K 0.17% 78
2021
Q4
$1.75M Buy
2,650
+186
+8% +$117K 0.2% 74
2021
Q3
$1.53M Buy
2,464
+143
+6% +$96.1K 0.19% 71
2021
Q2
$1.47M Buy
2,321
+52
+2% +$28.7K 0.19% 68
2021
Q1
$1.11M Buy
2,269
+63
+3% +$31.6K 0.16% 86
2020
Q4
$1.1M Buy
2,206
+62
+3% +$27.7K 0.17% 82
2020
Q3
$843K Buy
2,144
+152
+8% +$56.2K 0.15% 87
2020
Q2
$658K Buy
+1,992
New +$577K 0.12% 91

Other funds holding IDXX

Bell Bank's IDXX Position: Q3 2024 in Review

Bell Bank sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 1,727 shares — an estimated $841K sold.

Bell Bank first reported a position in IDXX in Q2 2020 and held it in 17 quarters. The position peaked at $1.75M in Q4 2021. 1,115 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Bell Bank reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Bell Bank sold 1,727 Idexx Laboratories shares in Q3 2024, an estimated $841K.
  • Bell Bank first reported a position in Idexx Laboratories in Q2 2020 and held it in 17 quarters.
  • Bell Bank's Idexx Laboratories position peaked at $1.75M in Q4 2021.
  • 1,115 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Bell Bank's 13F filing for Q3 2024, filed 6 Nov 2024.